Caplin Point Laboratories subsidiary gets FDA final approval for Thiamine Hydrochloride Injection
Caplin Point Laboratories said that its subsidiary Caplin Steriles has secured final approval for its abbreviated new drug application (ANDA) for Thiamine Hydrochloride Injection USP, 200 mg/2 mL (100 mg/mL) Multi-dose Vial from the US Food and Drug Administration (FDA). The approved product is a generic version of Fresenius Kabi USA’s THIAMINE HYDROCHLORIDE injection. It […]